vs
Side-by-side financial comparison of Hologic (HOLX) and SERVICE CORP INTERNATIONAL (SCI). Click either name above to swap in a different company.
SERVICE CORP INTERNATIONAL is the larger business by last-quarter revenue ($1.1B vs $1.0B, roughly 1.1× Hologic). Hologic runs the higher net margin — 17.1% vs 14.3%, a 2.8% gap on every dollar of revenue. On growth, Hologic posted the faster year-over-year revenue change (2.5% vs 1.7%). Hologic produced more free cash flow last quarter ($215.2M vs $87.2M). Over the past eight quarters, SERVICE CORP INTERNATIONAL's revenue compounded faster (3.1% CAGR vs 1.5%).
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
International Distribution Services Limited is a British company providing postal and courier services. IDS was created in 2013 by the UK government as a new holding company of Royal Mail, and a majority of its shares were then sold on the London Stock Exchange, with the government initially retaining a 30 per cent at the time. As of April 2025, IDS is owned and operated by Czech-based EP Group, owned by Daniel Křetínský.
HOLX vs SCI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $1.1B |
| Net Profit | $179.1M | $159.4M |
| Gross Margin | 56.0% | 28.0% |
| Operating Margin | 22.6% | 24.8% |
| Net Margin | 17.1% | 14.3% |
| Revenue YoY | 2.5% | 1.7% |
| Net Profit YoY | -10.9% | 5.3% |
| EPS (diluted) | $0.79 | $1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $1.0B | $1.1B | ||
| Q2 25 | $1.0B | $1.1B | ||
| Q1 25 | $1.0B | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $988.0M | $1.0B | ||
| Q2 24 | $1.0B | $1.0B | ||
| Q1 24 | $1.0B | $1.0B |
| Q4 25 | $179.1M | $159.4M | ||
| Q3 25 | $187.2M | $117.5M | ||
| Q2 25 | $194.9M | $122.9M | ||
| Q1 25 | $-17.4M | $142.9M | ||
| Q4 24 | $201.0M | $151.4M | ||
| Q3 24 | $178.6M | $117.8M | ||
| Q2 24 | $194.5M | $118.2M | ||
| Q1 24 | $169.9M | $131.3M |
| Q4 25 | 56.0% | 28.0% | ||
| Q3 25 | 55.6% | 25.1% | ||
| Q2 25 | 56.3% | 25.5% | ||
| Q1 25 | 37.5% | 27.1% | ||
| Q4 24 | 56.8% | 28.0% | ||
| Q3 24 | 56.4% | 24.9% | ||
| Q2 24 | 55.4% | 24.9% | ||
| Q1 24 | 53.3% | 26.2% |
| Q4 25 | 22.6% | 24.8% | ||
| Q3 25 | 22.6% | 21.4% | ||
| Q2 25 | 24.9% | 21.1% | ||
| Q1 25 | -0.7% | 23.4% | ||
| Q4 24 | 22.5% | 24.0% | ||
| Q3 24 | 23.3% | 20.9% | ||
| Q2 24 | 24.1% | 21.4% | ||
| Q1 24 | 20.7% | 22.2% |
| Q4 25 | 17.1% | 14.3% | ||
| Q3 25 | 17.8% | 11.1% | ||
| Q2 25 | 19.0% | 11.5% | ||
| Q1 25 | -1.7% | 13.3% | ||
| Q4 24 | 19.7% | 13.8% | ||
| Q3 24 | 18.1% | 11.6% | ||
| Q2 24 | 19.2% | 11.4% | ||
| Q1 24 | 16.7% | 12.6% |
| Q4 25 | $0.79 | $1.13 | ||
| Q3 25 | $0.84 | $0.83 | ||
| Q2 25 | $0.86 | $0.86 | ||
| Q1 25 | $-0.08 | $0.98 | ||
| Q4 24 | $0.87 | $1.02 | ||
| Q3 24 | $0.75 | $0.81 | ||
| Q2 24 | $0.82 | $0.81 | ||
| Q1 24 | $0.72 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.4B | $243.6M |
| Total DebtLower is stronger | $2.5B | $5.1B |
| Stockholders' EquityBook value | $5.2B | $1.6B |
| Total Assets | $9.2B | $18.7B |
| Debt / EquityLower = less leverage | 0.48× | 3.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.4B | $243.6M | ||
| Q3 25 | $2.2B | $241.3M | ||
| Q2 25 | $1.9B | $255.4M | ||
| Q1 25 | $1.6B | $227.2M | ||
| Q4 24 | $2.0B | $218.8M | ||
| Q3 24 | $2.3B | $185.4M | ||
| Q2 24 | $2.4B | $184.4M | ||
| Q1 24 | $2.2B | $205.6M |
| Q4 25 | $2.5B | $5.1B | ||
| Q3 25 | $2.5B | $5.0B | ||
| Q2 25 | $2.5B | $5.0B | ||
| Q1 25 | $2.5B | $4.7B | ||
| Q4 24 | $2.5B | $4.8B | ||
| Q3 24 | $2.5B | $4.7B | ||
| Q2 24 | $2.5B | $4.7B | ||
| Q1 24 | $2.6B | $4.6B |
| Q4 25 | $5.2B | $1.6B | ||
| Q3 25 | $5.0B | $1.6B | ||
| Q2 25 | $4.8B | $1.6B | ||
| Q1 25 | $4.6B | $1.7B | ||
| Q4 24 | $4.8B | $1.7B | ||
| Q3 24 | $5.1B | $1.6B | ||
| Q2 24 | $5.0B | $1.5B | ||
| Q1 24 | $4.8B | $1.6B |
| Q4 25 | $9.2B | $18.7B | ||
| Q3 25 | $9.0B | $18.4B | ||
| Q2 25 | $8.8B | $18.0B | ||
| Q1 25 | $8.5B | $17.3B | ||
| Q4 24 | $8.7B | $17.4B | ||
| Q3 24 | $9.2B | $17.4B | ||
| Q2 24 | $8.9B | $16.8B | ||
| Q1 24 | $8.7B | $16.7B |
| Q4 25 | 0.48× | 3.10× | ||
| Q3 25 | 0.50× | 3.17× | ||
| Q2 25 | 0.52× | 3.19× | ||
| Q1 25 | 0.55× | 2.87× | ||
| Q4 24 | 0.53× | 2.83× | ||
| Q3 24 | 0.49× | 2.92× | ||
| Q2 24 | 0.51× | 3.05× | ||
| Q1 24 | 0.53× | 2.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $229.9M | $212.9M |
| Free Cash FlowOCF − Capex | $215.2M | $87.2M |
| FCF MarginFCF / Revenue | 20.5% | 7.8% |
| Capex IntensityCapex / Revenue | 1.4% | 11.3% |
| Cash ConversionOCF / Net Profit | 1.28× | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | $1.0B | $554.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $229.9M | $212.9M | ||
| Q3 25 | $355.1M | $252.3M | ||
| Q2 25 | $343.3M | $166.4M | ||
| Q1 25 | $169.4M | $311.1M | ||
| Q4 24 | $189.3M | $264.1M | ||
| Q3 24 | $367.0M | $263.8M | ||
| Q2 24 | $405.8M | $196.9M | ||
| Q1 24 | $292.4M | $220.1M |
| Q4 25 | $215.2M | $87.2M | ||
| Q3 25 | $341.4M | $150.7M | ||
| Q2 25 | $330.5M | $83.4M | ||
| Q1 25 | $153.9M | $233.0M | ||
| Q4 24 | $172.5M | $151.8M | ||
| Q3 24 | $350.6M | $162.8M | ||
| Q2 24 | $385.3M | $100.8M | ||
| Q1 24 | $279.6M | $140.3M |
| Q4 25 | 20.5% | 7.8% | ||
| Q3 25 | 32.5% | 14.2% | ||
| Q2 25 | 32.3% | 7.8% | ||
| Q1 25 | 15.3% | 21.7% | ||
| Q4 24 | 16.9% | 13.9% | ||
| Q3 24 | 35.5% | 16.1% | ||
| Q2 24 | 38.1% | 9.7% | ||
| Q1 24 | 27.5% | 13.4% |
| Q4 25 | 1.4% | 11.3% | ||
| Q3 25 | 1.3% | 9.6% | ||
| Q2 25 | 1.3% | 7.8% | ||
| Q1 25 | 1.5% | 7.3% | ||
| Q4 24 | 1.6% | 10.3% | ||
| Q3 24 | 1.7% | 10.0% | ||
| Q2 24 | 2.0% | 9.3% | ||
| Q1 24 | 1.3% | 7.6% |
| Q4 25 | 1.28× | 1.34× | ||
| Q3 25 | 1.90× | 2.15× | ||
| Q2 25 | 1.76× | 1.35× | ||
| Q1 25 | — | 2.18× | ||
| Q4 24 | 0.94× | 1.75× | ||
| Q3 24 | 2.05× | 2.24× | ||
| Q2 24 | 2.09× | 1.67× | ||
| Q1 24 | 1.72× | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
SCI
| Cemetery | $510.9M | 46% |
| Funeral Matured Preneed Revenue | $196.5M | 18% |
| Cemetery Recognized Preneed Merchandise And Service Revenue | $107.4M | 10% |
| Cemetery Atneed Revenue | $104.9M | 9% |
| CA | $56.4M | 5% |
| Funeral Other Revenue | $54.6M | 5% |
| Cemetery Other Revenue | $40.2M | 4% |
| Nonfuneral Home Revenue | $28.1M | 3% |
| Non Funeral Home Preneed Sales Revenue | $22.0M | 2% |
